In isolated rat islets and in mouse insulinoma beta TC-1 cells, Exendin-4 stimulated the glucose-induced insulin secretion in a dose dependent manner [2]

The Canadian Peptide Research Society is one organization helping advance peptide science in Canada through: research collaboration education and training scientific conferences and knowledge sharing exploration of emerging clinical applications You can learn more about their work here: Current research efforts in Canada and internationally are focused on: developing peptide-based medications (e.g., metabolic and hormone therapies) understanding how peptides influence tissue repair and inflammation advancing drug discovery and personalized medicine However, in musculoskeletal medicine specifically: most research remains preclinical (animal and laboratory studies) high-quality human clinical trials are still limited What this means for patients: Peptide research is an active and evolving field, and Canada is contributing to its development

"There are the lucky ones that have some form of coverage that is also affordable, but they are few and far between." says Tracy Zvenyach, vice president of advocacy and research at the nonprofit Obesity Action Coalition, which receives financial support from drugmakers, including Eli Lilly and Novo Nordisk
So, let's have a real, unflinching conversation about the central question: can BPC-157 heal a meniscus
10.1038/s41386-018-0010-3 26 HernandezN